Joint Status Report and Stipulation of Dismissal Re: 340B Delayed Regulations on Transparency and CMPs

Key Resources

Related Resources

Letter/Comment
AHA Submits Comments on CMS Guidance For Medicare Drug Price Negotiation Program
Public
Letter/Comment
AHA Letter to House Energy and Commerce Committees on Value of 340B Program
Public
Action Alert
Contact your Representative Prior to June 4 House Subcommittee Hearing on 340B
Member Non-Fed
Advisory
HRSA Finalizes 340B Administrative Dispute Resolution Process
Member
Letter/Comment
AHA Responds to Senate RFI on the SUSTAIN 340B Act Draft
Guides/Reports
The 340B Drug Pricing Program